|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.73 USD | +8.81% |
|
-1.14% | +200.87% |
| May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
| May. 31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
Ocugen, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 1.01 million compared to USD 0.443 million a year ago. Net loss was USD 11.92 million compared to USD 17.33 million a year ago.
Basic loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to USD 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +200.87% | 445M | |
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B |
OCUGEN, INC. 
